CF Community Blog

JP Clancy

Vice President of Clinical Research, Cystic Fibrosis Foundation

Learn more about JP Clancy

  1. We Are at a Transformative Time in the History of CF

    By JP Clancy November 1, 2019

    The recent approval of a game-changing triple-combination therapy and the announcement of a major infusion of research funding are just two reasons why we are at a pivotal time in cystic fibrosis and why this year’s North American Cystic Fibrosis Conference in Nashville, Tenn., has been so exciting.

About JP Clancy

JP is the vice president of clinical research for the Cystic Fibrosis Foundation and a professor of pediatric pulmonary medicine at Cincinnati Children's Hospital Medical Center. His role at the Foundation is to oversee clinical research conducted by the Foundation's Therapeutics Development Network and investigators from academic institutions internationally. He also is deeply involved in the education and training of physician-scientists and career development in CF research. JP has over 250 peer-reviewed publications and regularly provides leadership in clinical and translational research through the international CF research community.

This site contains general information about cystic fibrosis, as well as personal insight from the CF community. Opinions and experiences shared by members of our community, including but not limited to people with CF and their families, belong solely to the blog post author and do not represent those of  the Cystic Fibrosis Foundation, unless explicitly stated. In addition, the site is not intended as a substitute for treatment advice from a medical professional. Consult your doctor before making any changes to your treatment.